Grünert A
Abt. Experimentelle Anästhesie, Klinikum der Universität Ulm, Donau.
Infusionsther Klin Ernahr. 1987 Sep;14 Suppl 3:10-8.
Modern fat emulsions are being applied with increasing frequently in clinical nutrition. The adverse reactions observed at the beginning of the development of fat emulsions had a strong negative influence on the use of such preparations. In this study, modern fat emulsions are presented and characterized on the basis of the huge amount of experimental and clinical data and knowledge gained to date. The profile of applications has changed drastically during the last few years, especially due to the results of membrane studies, because fatty acid derivatives have been discovered to be important parts of such structures. This knowledge has enhanced the area of indications which before were determined by the energetical aspects and the essentiality of fatty acids only. As a remarkable development we discuss the changed basis of indications, which moved from the simple presence of a specific nosological entity such as renal failure or sepsis to criteria of blood substrate composition for proving and selecting indications. Pharmacokinetic studies are presented which have provided data for physiological dosages. As influencing factors apart from hormonal constellations and pathophysiological functions of posttraumatic metabolism, body weight is discussed in respect to concentrations of triglycerides in plasma. On the basis of our clinical studies on applications of fat emulsions in intensive-care patients, preconditions are defined which must be considered before the use of fat. Finally, pathophysiological interactions between carbohydrate- and fat metabolism result in an analytical control system which is proposed for the surveillance of fat applications especially in destabilized intensive-care patients.
现代脂肪乳剂在临床营养中的应用日益频繁。脂肪乳剂开发初期观察到的不良反应对这类制剂的使用产生了很大的负面影响。在本研究中,基于迄今为止获得的大量实验和临床数据及知识,对现代脂肪乳剂进行了介绍和特性描述。在过去几年中,应用情况发生了巨大变化,尤其是由于膜研究的结果,因为已发现脂肪酸衍生物是这些结构的重要组成部分。这一知识拓展了适应证范围,此前适应证仅由能量方面和脂肪酸的必需性决定。作为一个显著的发展,我们讨论了适应证依据的变化,从单纯存在特定疾病实体(如肾衰竭或脓毒症)转变为用于证明和选择适应证的血液底物组成标准。文中介绍了药代动力学研究,这些研究为生理剂量提供了数据。除了激素状态和创伤后代谢的病理生理功能外,作为影响因素,还讨论了体重与血浆甘油三酯浓度的关系。基于我们对重症监护患者应用脂肪乳剂的临床研究,确定了使用脂肪前必须考虑的前提条件。最后,碳水化合物和脂肪代谢之间的病理生理相互作用产生了一个分析控制系统,该系统被提议用于监测脂肪的应用,尤其是在病情不稳定的重症监护患者中。